• Japanese
  • Korean
  • Chinese
Cover Image

Transdermal Drug Patches to 2020: Products, Indications, Markets and Forecasts

Greystone Research Associates is pleased to announce the publication of a new market study. ‘Transdermal Drug Patches: Products, Indications, Markets and Forecasts’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for prescription drugs packaged and supplied in transdermal patches. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Engineering Evolution, Generic Drugs and the Re-discovery of the Transdermal Patch

Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2018.

Feature Summary

  • Analyzes and evaluates current transdermal drug patch markets and products and assesses the market potential for existing and probable future products
  • Analyzes patch designs, technologies and patch development issues
  • Profiles patch manufacturers and third-party transdermal supply chain companies
  • Provides detailed assessments of more than forty patch products in more than a dozen product categories
  • Provides market data and forecasts to 2018
  • Profiles transdermal drug patch product providers, their product development activity, and strategies
  • Evaluates the impact of economic, technology, and regulatory factors

Table of Contents

Executive Summary

The Market Opportunity

  • Transdermal Drug Delivery Dynamics
  • Demand Drivers
  • Competitive Landscape
  • Factors Limiting Growth
  • Pharmacokinetics & Dosage Forms
  • Patch Manufacturing Dynamics
  • Patch Manufacturing Company Profiles

Product Analysis - FDA-Approved Drugs Delivered via Transdermal Patches

  • Alkaloids
  • Androgens
  • Antidepressants
  • Antiemetics
  • Antispasmodics
  • CNS Stimulants
  • Cholinesterase Inhibitors
  • Dopamine Agonists
  • Hormone Replacement
  • Hypotensive Agents
  • Local Anesthetics
  • NSAIDs
  • Opioid Analgesics
  • Progestrins
  • Trinitrates

Market Analysis - Transdermal Drug Patch Therapeutics

  • ADHD
  • Addiction
  • Contraception
  • Cardiovascular/Angina
  • Depression
  • Hormone Replacement Therapy
  • Hypertension
  • Motion Sickness
  • Neurology
  • Osteoporosis
  • Pain Management

Market Factors

  • Regulatory Issues
  • IP and Expiring Patents
  • Rx-to-OTC Switching
  • Patient Compliance and Ease of Use
  • Healthcare Economics

Company Profiles

Note: The Table of Contents has Been Edited for Brevity. For a Completed Version, Please Request a Free Sample.

Show More
Pricing
Get Notified
Email me when related reports are published